Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v12-FR | Version v7-EN | |
---|---|---|
Language | French | English |
Date Updated | 2018-02-05 | 2018-01-10 |
Drug Identification Number | 02431130 | 02431130 |
Brand name | VINORELBINE INJECTION, USP | VINORELBINE INJECTION, USP |
Common or Proper name | 10 mg/ml Vinorelbine (as vinorelbine tartrate) | 10 mg/ml Vinorelbine (as vinorelbine tartrate) |
Company Name | GENERIC MEDICAL PARTNERS INC | GENERIC MEDICAL PARTNERS INC |
Ingredients | VINORELBINE | VINORELBINE |
Strength(s) | 10MG | 10MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 5ml in clear glass vial | 5ml in clear glass vial |
ATC code | L01CA | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
Anticipated start date | ||
Actual start date | 2017-12-06 | 2017-12-06 |
Estimated end date | 2018-03-15 | 2018-01-30 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Vinorelbine production process has identified an issue that requires changes. Changes are being made. New batches are in production with planned release dates mid March. | Any new information on date of availability will be provided as soon as available. |
Health Canada comments |